164 related articles for article (PubMed ID: 37936324)
1. Inhibition of ATR opposes glioblastoma invasion through disruption of cytoskeletal networks and integrin internalization via macropinocytosis.
Derby SJ; Dutton L; Strathdee KE; Stevenson K; Koessinger A; Jackson M; Tian Y; Yu W; Mclay K; Misquitta J; Alsharif S; Clarke CJ; Gilmour L; Thomason P; McGhee E; McGarrity-Cottrell CL; Vanderlinden A; Collis SJ; Rominyi O; Lemgruber L; Solecki G; Olson M; Winkler F; Carlin LM; Heiland DH; Inman GJ; Chalmers AJ; Norman JC; Carruthers R; Birch JL
Neuro Oncol; 2024 Apr; 26(4):625-639. PubMed ID: 37936324
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of [
Carlucci G; Carney B; Sadique A; Vansteene A; Tang J; Reiner T
Nucl Med Biol; 2017 May; 48():9-15. PubMed ID: 28157626
[TBL] [Abstract][Full Text] [Related]
3. Functionally-instructed modifiers of response to ATR inhibition in experimental glioma.
Walter B; Hirsch S; Kuhlburger L; Stahl A; Schnabel L; Wisser S; Haeusser LA; Tsiami F; Plöger S; Aghaallaei N; Dick AM; Skokowa J; Schmees C; Templin M; Schenke-Layland K; Tatagiba M; Nahnsen S; Merk DJ; Tabatabai G
J Exp Clin Cancer Res; 2024 Mar; 43(1):77. PubMed ID: 38475864
[TBL] [Abstract][Full Text] [Related]
4. Motility of glioblastoma cells is driven by netrin-1 induced gain of stemness.
Ylivinkka I; Sihto H; Tynninen O; Hu Y; Laakso A; Kivisaari R; Laakkonen P; Keski-Oja J; Hyytiäinen M
J Exp Clin Cancer Res; 2017 Jan; 36(1):9. PubMed ID: 28069038
[TBL] [Abstract][Full Text] [Related]
5. ATR inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell lines.
Lozinski M; Bowden NA; Graves MC; Fay M; Day BW; Stringer BW; Tooney PA
Oncotarget; 2024 Jan; 15():1-18. PubMed ID: 38227740
[TBL] [Abstract][Full Text] [Related]
6. Contribution of ATM and ATR to the resistance of glioblastoma and malignant melanoma cells to the methylating anticancer drug temozolomide.
Eich M; Roos WP; Nikolova T; Kaina B
Mol Cancer Ther; 2013 Nov; 12(11):2529-40. PubMed ID: 23960094
[TBL] [Abstract][Full Text] [Related]
7. The Cytoskeleton Effectors Rho-Kinase (ROCK) and Mammalian Diaphanous-Related (mDia) Formin Have Dynamic Roles in Tumor Microtube Formation in Invasive Glioblastoma Cells.
Becker KN; Pettee KM; Sugrue A; Reinard KA; Schroeder JL; Eisenmann KM
Cells; 2022 May; 11(9):. PubMed ID: 35563863
[TBL] [Abstract][Full Text] [Related]
8. The Error-Prone DNA Polymerase κ Promotes Temozolomide Resistance in Glioblastoma through Rad17-Dependent Activation of ATR-Chk1 Signaling.
Peng C; Chen Z; Wang S; Wang HW; Qiu W; Zhao L; Xu R; Luo H; Chen Y; Chen D; You Y; Liu N; Wang H
Cancer Res; 2016 Apr; 76(8):2340-53. PubMed ID: 26960975
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances in Synergistic Antitumor Effects Exploited from the Inhibition of Ataxia Telangiectasia and RAD3-Related Protein Kinase (ATR).
Wang LW; Jiang S; Yuan YH; Duan J; Mao ND; Hui Z; Bai R; Xie T; Ye XY
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458687
[TBL] [Abstract][Full Text] [Related]
10. MiR-148a inhibits the proliferation and migration of glioblastoma by targeting ITGA9.
Xu TJ; Qiu P; Zhang YB; Yu SY; Xu GM; Yang W
Hum Cell; 2019 Oct; 32(4):548-556. PubMed ID: 31489579
[TBL] [Abstract][Full Text] [Related]
11. PHIP drives glioblastoma motility and invasion by regulating the focal adhesion complex.
de Semir D; Bezrookove V; Nosrati M; Scanlon KR; Singer E; Judkins J; Rieken C; Wu C; Shen J; Schmudermayer C; Dar AA; Miller JR; Cobbs C; Yount G; Desprez PY; Debs RJ; Salomonis N; McAllister S; Cleaver JE; Soroceanu L; Kashani-Sabet M
Proc Natl Acad Sci U S A; 2020 Apr; 117(16):9064-9073. PubMed ID: 32273388
[TBL] [Abstract][Full Text] [Related]
12. ACTL6A deficiency induces apoptosis through impairing DNA replication and inhibiting the ATR-Chk1 signaling in glioblastoma cells.
Hu X; Pei D; Ci M; Zhang G; Li B; Wang J; Shen Y; Zhai X; Liang P; Cui H
Biochem Biophys Res Commun; 2022 Apr; 599():148-155. PubMed ID: 35182941
[TBL] [Abstract][Full Text] [Related]
13. CD151-α3β1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion.
Zhou P; Erfani S; Liu Z; Jia C; Chen Y; Xu B; Deng X; Alfáro JE; Chen L; Napier D; Lu M; Huang JA; Liu C; Thibault O; Segal R; Zhou BP; Kyprianou N; Horbinski C; Yang XH
Oncotarget; 2015 Oct; 6(30):29675-93. PubMed ID: 26377974
[TBL] [Abstract][Full Text] [Related]
14. Glioblastoma recurrent cells switch between ATM and ATR pathway as an alternative strategy to survive radiation stress.
Kaur E; Ketkar M; Dutt S
Med Oncol; 2022 Feb; 39(5):50. PubMed ID: 35150325
[TBL] [Abstract][Full Text] [Related]
15. The Cytoskeletal Adapter Protein Spinophilin Regulates Invadopodia Dynamics and Tumor Cell Invasion in Glioblastoma.
Cheerathodi M; Avci NG; Guerrero PA; Tang LK; Popp J; Morales JE; Chen Z; Carnero A; Lang FF; Ballif BA; Rivera GM; McCarty JH
Mol Cancer Res; 2016 Dec; 14(12):1277-1287. PubMed ID: 27655131
[TBL] [Abstract][Full Text] [Related]
16. Rhoj Is a Novel Target for Progression and Invasion of Glioblastoma by Impairing Cytoskeleton Dynamics.
Wang M; Jiang X; Yang Y; Chen H; Zhang C; Xu H; Qi B; Yao C; Xia H
Neurotherapeutics; 2020 Oct; 17(4):2028-2040. PubMed ID: 32822001
[TBL] [Abstract][Full Text] [Related]
17. Oct-3/4 promotes migration and invasion of glioblastoma cells.
Kobayashi K; Takahashi H; Inoue A; Harada H; Toshimori S; Kobayashi Y; Goto K; Sugimoto K; Yano H; Ohnishi T; Tanaka J
J Cell Biochem; 2012 Feb; 113(2):508-17. PubMed ID: 21938739
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and toxicity of ATM inhibition in glioblastoma initiating cells-driven tumor models.
Frosina G; Marubbi D; Marcello D; Vecchio D; Daga A
Crit Rev Oncol Hematol; 2019 Jun; 138():214-222. PubMed ID: 31092378
[TBL] [Abstract][Full Text] [Related]
19. Girdin, an actin-binding protein, is critical for migration, adhesion, and invasion of human glioblastoma cells.
Gu F; Wang L; He J; Liu X; Zhang H; Li W; Fu L; Ma Y
J Neurochem; 2014 Nov; 131(4):457-69. PubMed ID: 25060559
[TBL] [Abstract][Full Text] [Related]
20. Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer.
Abdel-Fatah TM; Middleton FK; Arora A; Agarwal D; Chen T; Moseley PM; Perry C; Doherty R; Chan S; Green AR; Rakha E; Ball G; Ellis IO; Curtin NJ; Madhusudan S
Mol Oncol; 2015 Mar; 9(3):569-85. PubMed ID: 25468710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
